Evidence map›Paper›PMID 32381016›Full record

ArticleMolecular cancer2020

Circular RNA circ_0020710 drives tumor progression and immune evasion by regulating the miR-370-3p/CXCL12 axis in melanoma.

Chuan-Yuan Wei, Meng-Xuan Zhu, Nan-Hang Lu, Jia-Qi Liu, Yan-Wen Yang, Yong Zhang, Yue-Dong Shi, Zi-Hao Feng, Jia-Xia Li, Fa-Zhi Qi and 1 more

Abstract read
In one paragraph

Article in Molecular cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Circular RNA as a Potential Biomarker for Melanoma: A Systematic Review.Frontiers in cell and developmental biology · 2021
    Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Circular RNAs: key players in tumor immune evasion.Molecular and cellular biochemistry · 2025
    Review
  18. Review
  19. Review
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chuan-Yuan WeiDepartment of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China.
Meng-Xuan ZhuDepartment of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China.
Nan-Hang LuDepartment of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China.
Jia-Qi LiuDepartment of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China.
Yan-Wen YangDepartment of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China.
Yong ZhangDepartment of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China.
Yue-Dong ShiDepartment of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China.
Zi-Hao FengDepartment of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China.
Jia-Xia LiDepartment of Neurology, Hefei Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230000, P. R. China.
Fa-Zhi QiDepartment of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China. qi.fazhi@zs-hospital.sh.cn.
Jian-Ying GuDepartment of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China. zhongshanhospital@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCircular RNAs (circRNAs) have been reported to have critical regulatory roles in tumor biology. However, their contribution to melanoma remains largely unknown.

methodsCircRNAs derived from oncogene CD151 were detected and verified by analyzing a large number of melanoma samples through quantitative real-time polymerase chain reaction (qRT-PCR). Melanoma cells were stably transfected with lentiviruses using circ_0020710 interference or overexpression plasmid, and then CCK-8, colony formation, wound healing, transwell invasion assays, and mouse xenograft models were employed to assess the potential role of circ_0020710. RNA immunoprecipitation, luciferase reporter assay and fluorescence in situ hybridization were used to evaluate the underlying mechanism of circ_0020710.

resultsOur findings indicated that circ_0020710 was generally overexpressed in melanoma tissues, and high level of circ_0020710 was positively correlated with malignant phenotype and poor prognosis of melanoma patients. Elevated circ_0020710 promoted melanoma cell proliferation, migration and invasion in vitro as well as tumor growth in vivo. Mechanistically, we found that high level of circ_0020710 could upregulate the CXCL12 expression via sponging miR-370-3p. CXCL12 downregulation could reverse the malignant behavior of melanoma cells conferred by circ_0020710 over expression. Moreover, we also found that elevated circ_0020710 was correlated with cytotoxic lymphocyte exhaustion, and a combination of AMD3100 (the CXCL12/CXCR4 axis inhibitor) and anti-PD-1 significantly attenuated tumor growth.

conclusionsElevated circ_0020710 drives tumor progression via the miR-370-3p/CXCL12 axis, and circ_0020710 is a potential target for melanoma treatment.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsApoptosisBiomarkers, TumorCase-Control StudiesCell MovementCell ProliferationChemokine CXCL12Disease ProgressionFemaleHumansImmune EvasionMaleMelanomaMiceMice, Inbred C57BLBiomarkers, TumorCD151 protein, humanChemokine CXCL12CXCL12 protein, humanMicroRNAsMIRN370 microRNA, humanRNA, CircularTetraspanin 24circRNAsCXCL12Immune suppressionMelanoma

Identifiers

PMID32381016
PMCPMC7204052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.